Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain implant learns to read OCD signals in tiny pilot study

NCT ID NCT03457675

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early study tests an adaptive deep brain stimulation (aDBS) system in 2 people with severe, treatment-resistant OCD. The device records brain signals to identify patterns linked to OCD distress and stimulation side effects. The goal is not to treat OCD now, but to gather data needed to build a future system that automatically adjusts stimulation for better symptom control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Deep brain stimulation (DBS) device
What this could lead to
If successful, this could pave the way for a smarter DBS system that automatically adjusts stimulation to better control OCD symptoms and reduce side effects.
What could go wrong
This is a very early, tiny study with only 2 participants, focused on gathering data rather than proving treatment works. The approach may not lead to a usable system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2 people

The number who actually took part.

Started

Jul 2018

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * OCD DBS Subject Inclusion criteria: 1. Signed informed consent prior to any study specific procedures being performed 2. Male or female between ages 21 and 70; 3. At least a five-year history of treatment-refractory OCD that causes substantial subjective distress and impairment in functioning; 4. Y-BOCS minimum score of 28; 5. Failed an adequate trial of at least three of the following SSRIs: Fluoxetine; fluvoxamine; citalopram; escitalopram; sertraline; paroxetine; 6. Failed an adequate trial of clomipramine; 7. Failed augmentation of one or more of the aforementioned drugs with at least one of the following antipsychotics: haloperidol; risperidone; quetiapine; ziprasidone; aripiprazole; 8. Failed an adequate trial of CBT for OCD, defined as 25 hours of documented exposure and response prevention (ERP) by an expert therapist; 9. Stable psychotropic medical regimen for the month preceding surgery * Non-Implanted Control Subject Inclusion criteria: 1. Signed informed consent prior to any study specific procedures being performed 2. Male or female between ages 21 and 70 * Implanted ET Subject Inclusion criteria: 1. Signed informed consent prior to any study specific procedures being performed 2. Male or female between ages 21 and 70 3. Diagnosed with Essential Tremor (ET) chronically, EXCLUDING head tremor, and implanted with DBS Exclusion Criteria: * OCD DBS Subject Exclusion criteria: 1. Inability or refusal to give informed consent. 2. Lifetime diagnosis of psychotic disorders such as schizophrenia; 3. Alcohol or substance abuse/dependence within 6 months, excluding nicotine; 4. Deemed at high risk of suicidal behavior or impulsivity, per clinical opinion assessments. 5. Any Neurological/Medical condition that makes the subject, in the opinion of the surgeon, a poor candidate. 6. Pregnant (confirmed by serum pregnancy test on females of child bearing age) or plans to become pregnant in the next 24 months. 7. Need for Diathermy 8. Contraindications to MRI * Non-Implanted Control Subject Exclusion criteria: 1. Inability or refusal to give informed consent. 2. Lifetime diagnosis of mental illness 3. A score of 8 or greater on part B of the Florida Obsessive Compulsive Inventory 4. Any neurological disorders (i.e., MS, Parkinson's Disease, seizure disorders, etc.) or evidence of brain abnormalities/injury, such as tumor, stroke, or traumatic brain injury 5. Pregnant (confirmed by self-report for females of child bearing age) 6. Contraindications to MRI * Implanted ET Subject Exclusion criteria 1. ET subjects (with DBS implanted), WITH head tremor, may exacerbate artifact, therefore they will be excluded. 2. Inability or refusal to give informed consent. 3. Lifetime diagnosis of mental illness 4. A score of 8 or greater on part B of the Florida Obsessive Compulsive Inventory 5. Any other neurological disorder other than ET (i.e., MS, Parkinson's Disease, seizure disorders, etc.) or evidence of brain abnormalities/injury, such as tumor, stroke, or traumatic brain injury 6. Contraindications to MRI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Essential tremor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Brown University

    Providence, Rhode Island, 02912, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.